These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 20135077

  • 21. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 22. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Zumalde J, Salvador A, Mataix L, NASPEAF Investigators.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1557-66. PubMed ID: 15489085
    [Abstract] [Full Text] [Related]

  • 23. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
    Tangelder MJ, Frison L, Weaver D, Wilcox RG, Bylock A, Emanuelsson H, Held P, Oldgren J.
    Am Heart J; 2008 Feb 19; 155(2):382-7. PubMed ID: 18215612
    [Abstract] [Full Text] [Related]

  • 24. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
    Sambola A, Montoro JB, Del Blanco BG, Llavero N, Barrabés JA, Alfonso F, Bueno H, Cequier A, Serra A, Zueco J, Sabaté M, Rodríguez-Leor O, García-Dorado D.
    Am Heart J; 2013 Oct 19; 166(4):669-75. PubMed ID: 24093846
    [Abstract] [Full Text] [Related]

  • 25. A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care.
    Mazzaglia G, Filippi A, Alacqua M, Cowell W, Shakespeare A, Mantovani LG, Bianchi C, Cricelli C.
    Thromb Haemost; 2010 May 19; 103(5):968-75. PubMed ID: 20216987
    [Abstract] [Full Text] [Related]

  • 26. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 19; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Nov 19; 27(1):74-90. PubMed ID: 21329865
    [Abstract] [Full Text] [Related]

  • 29. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM.
    Cerebrovasc Dis; 2013 Nov 19; 36(4):273-80. PubMed ID: 24135809
    [Abstract] [Full Text] [Related]

  • 30. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ, Schenk B, Tietz V, Schenkel J, Heuschmann PU.
    Cerebrovasc Dis; 2008 Nov 19; 26(2):171-7. PubMed ID: 18628615
    [Abstract] [Full Text] [Related]

  • 31. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL, Dublin S, Smith NL, French B, Jackson LA, Hrachovec JB, Siscovick DS, Psaty BM, Heckbert SR.
    Arch Intern Med; 2007 Feb 12; 167(3):246-52. PubMed ID: 17296879
    [Abstract] [Full Text] [Related]

  • 32. [Oral anticoagulant use in patients with atrial fibrillation].
    Ertaş F, Duygu H, Acet H, Eren NK, Nazli C, Ergene AO.
    Turk Kardiyol Dern Ars; 2009 Apr 12; 37(3):161-7. PubMed ID: 19553738
    [Abstract] [Full Text] [Related]

  • 33. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M, AFFIRM Investigators.
    Am Heart J; 2005 Apr 12; 149(4):650-6. PubMed ID: 15990748
    [Abstract] [Full Text] [Related]

  • 34. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH.
    Arch Intern Med; 1996 Nov 11; 156(20):2311-6. PubMed ID: 8911237
    [Abstract] [Full Text] [Related]

  • 35. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC, Albers GW.
    Clin Geriatr Med; 1999 Nov 11; 15(4):645-62. PubMed ID: 10499928
    [Abstract] [Full Text] [Related]

  • 36. [Thrombotic risk factors and antithrombotic treatment in atrial fibrillation].
    Bounhoure JP.
    Bull Acad Natl Med; 2011 Nov 11; 195(4-5):963-74; discussion 974-7. PubMed ID: 22375363
    [Abstract] [Full Text] [Related]

  • 37. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.
    Can J Cardiol; 2005 Mar 11; 21(3):257-66. PubMed ID: 15776115
    [Abstract] [Full Text] [Related]

  • 38. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006.
    Béjot Y, Ben Salem D, Osseby GV, Couvreur G, Durier J, Marie C, Cottin Y, Moreau T, Giroud M.
    Neurology; 2009 Jan 27; 72(4):346-53. PubMed ID: 19171832
    [Abstract] [Full Text] [Related]

  • 39. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.
    Thromb Haemost; 2012 Jun 27; 107(6):1172-9. PubMed ID: 22473219
    [Abstract] [Full Text] [Related]

  • 40. Outcome of atrial fibrillation among patients with end-stage renal disease.
    Chou CY, Kuo HL, Wang SM, Liu JH, Lin HH, Liu YL, Huang CC.
    Nephrol Dial Transplant; 2010 Apr 27; 25(4):1225-30. PubMed ID: 19923144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.